Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTED: Packard and Microarrays

NEW YORK, Jan 17 – A January 8 story about Packard BioScience has been clarified to reflect the company’s decision not to commercialize DNA chips, not microarrays, as previously stated. While the company has decided not to market DNA chips, Packard BioScience still intends to sell its microarray technology and to manufacture and sell protein chips.

The archived version of the story has been altered to more clearly reflect the company’s plans.

GenomeWeb apologizes for any confusion.   

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.